CORBION
Corbion N.V. offers lactic acid products, ferment, enzymes, minerals, vitamins, and algae worldwide. It provides ingredient solutions for various markets, including food, home care, animal nutrition, supplements, pharmaceuticals, medical devices, and bioplastics. Products are marketed through a network of offices and distributors. The company was previously CSM N.V., renamed Corbion N.V. in 2013. Founded in 1919, it is headquartered in Amsterdam, Netherlands.
Overview
Strengths
- Current Price to Earnings Ratio (5.00) is lower than the sector mean (34.88).
- Price to book ratio (1.24) is lower than the sector mean (6.31).
- EV/EBITDA (7.92) is lower than the sector mean (18.32).
- EV/EBIT (15.98) is lower than the sector mean.
- Price to free cash flow (9.62) is lower than the sector mean.
Weaknesses
- With a depreciation Potential of -86.84%, based on our fundamental analysis, it suggests the stock may be overvalued.
- Analysts expect revenues to decline in the coming year.
- The company has high debt. Net Debt to EBITDA Ratio (2.33) is higher than the sector mean.
Key Financial Data
| Indicator | Value |
|---|
| PER | 5.0 |
| EV/EBITDA | 7.9 |
| Price/Free Cash Flow' | 9.6 |
| ROIC | 15.1% |
| Net Debt/EBITDA | 2.3 |